Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (51-60 of 250) with videos related to

Pageof 25
Sort By:
Translational Lung Cancer Research|March 10, 2023
Surgical series in mesothelioma: navigating between biasesJo Raskin, Paul E Van Schil, Jan P Van Meerbeeck
The European Respiratory Journal|January 2, 2010
Treatment of extensive-stage small cell lung carcinoma: current status and future prospectsI K Demedts, K Y Vermaelen, J P van Meerbeeck
Expert Review of Anticancer Therapy|June 17, 2014
Novel treatment options in stage I non-small-cell lung cancerSvitlana Tarasevych, Patrick Lauwers, Frederik Vandaele, et al.
Lung Cancer (Amsterdam, Netherlands)|August 6, 2016
O<sup>6</sup>-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?Birgitta I Hiddinga, Patrick Pauwels, Annelies Janssens, et al.
The European Respiratory Journal|May 26, 2018
Aminopeptidase antibodies in mesothelioma: new wine deserves new sacksJan P van Meerbeeck, Gerrit Jansen, Elisa Giovannetti, et al.
Current Opinion in Pulmonary Medicine|May 26, 2009
What is the role for surgery in patients with stage III non-small cell lung cancer?Elke Vandenbroucke, Frederic De Ryck, Veerle Surmont, et al.
Acta Clinica Belgica|January 15, 2020
Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS dataBenoît Colinet, Jan P Van Meerbeeck, Tine Cuppens, et al.
Oncotarget|September 9, 2017
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?Sabrina Lagniau, Kevin Lamote, Jan P van Meerbeeck, et al.
Frontiers in Oncology|February 6, 2023
Editorial: Imaging assessment of response to immunotherapyMariaelena Occhipinti, Andrea R Filippi, Sean Walsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancerJan P Van Meerbeeck, Paul E Y Van Schil, Suresh Senan, et al.
Pageof 25

Showing results (51-60 of 250) with videos related to

Sort By:
Pageof 25
Translational Lung Cancer Research|March 10, 2023
Surgical series in mesothelioma: navigating between biasesJo Raskin, Paul E Van Schil, Jan P Van Meerbeeck
The European Respiratory Journal|January 2, 2010
Treatment of extensive-stage small cell lung carcinoma: current status and future prospectsI K Demedts, K Y Vermaelen, J P van Meerbeeck
Expert Review of Anticancer Therapy|June 17, 2014
Novel treatment options in stage I non-small-cell lung cancerSvitlana Tarasevych, Patrick Lauwers, Frederik Vandaele, et al.
Lung Cancer (Amsterdam, Netherlands)|August 6, 2016
O<sup>6</sup>-Methylguanine-DNA methyltransferase (MGMT): A drugable target in lung cancer?Birgitta I Hiddinga, Patrick Pauwels, Annelies Janssens, et al.
The European Respiratory Journal|May 26, 2018
Aminopeptidase antibodies in mesothelioma: new wine deserves new sacksJan P van Meerbeeck, Gerrit Jansen, Elisa Giovannetti, et al.
Current Opinion in Pulmonary Medicine|May 26, 2009
What is the role for surgery in patients with stage III non-small cell lung cancer?Elke Vandenbroucke, Frederic De Ryck, Veerle Surmont, et al.
Acta Clinica Belgica|January 15, 2020
Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS dataBenoît Colinet, Jan P Van Meerbeeck, Tine Cuppens, et al.
Oncotarget|September 9, 2017
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?Sabrina Lagniau, Kevin Lamote, Jan P van Meerbeeck, et al.
Frontiers in Oncology|February 6, 2023
Editorial: Imaging assessment of response to immunotherapyMariaelena Occhipinti, Andrea R Filippi, Sean Walsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancerJan P Van Meerbeeck, Paul E Y Van Schil, Suresh Senan, et al.
Pageof 25